http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID252851_PMID15456268

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103455602_AID252851_PMID15456268_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123097261_AID252851_PMID15456268_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103455417_AID252851_PMID15456268_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103449955_AID252851_PMID15456268_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103455789_AID252851_PMID15456268_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103455265_AID252851_PMID15456268_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103455631_AID252851_PMID15456268_VALUE5
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID377
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Ratio of IC50 against sensitive LoVo cell line and that of doxorubicin resistance LoVo cell line was determined after 1 hr exposure
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103455789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103455602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103455265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103455631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103449955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123097261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103455417
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID252851

Total number of triples: 19.